PHARVAT is a European Commission (EC) Seventh Framework Programme (FP7) funded project aiming to generate a harmonised procedure to permit pre-clinical selection of vaccine adjuvants. The project is running for a two year period and was initiated in November 2009 with an overall budget of € 300 000.


17 June 2015

BELLEROPHON Call for process development and GMP manufacture of a vaccine candidate

BELLEROPHON would like to make a call for the process development and production in E. coli according to Good Manufacturing Practice (GMP) of a protein vaccine candidate to be used in toxicological and phase I studies.  The subcontracting is expected in Q4 2015.

17 June 2015

MVVC/MVVC 2 meeting, Oxford 4 - 5 March 2015

The annual meeting of MVVC / MVVC 2 held in Oxford in March is mentioned in the EDCTP May news letter (page 6).  Field trials of a new combination malaria vaccine, which are an integral part of the MVVC2 project, are funded by among others EDCTP.

13 June 2015

EVI Rendez-Vous 2015

Want to learn more about what EVI is doing, then join us for the 2015 Rendez-Vous on 9 December.

It is an increasing popular event, bringing together people from all corners of the scientific community, the European Commission and other like funders.